ReproCELL Incorporated announces private placement of 16th stock acquisition rights on December 5, 2023. The company will issue 100,000 units of stock acquisition rights at an issue price of ¥53 per unit for gross proceeds of ¥5,300,000. Each stock acquisition right is exercisable into 100 common share at a price of ¥126 and will receive proceeds of ¥2,088,300,000 on post exercise of stock acquisition rights.

The transaction will include participation from Morgan Stanley MUFG Securities Co., Ltd. The stock acquisition rights are issued through a third party allotment method. The transaction has been approved by the board of directors of the company. The transaction is expected to close on December 21, 2023.